Sign up to save your podcasts
Or
Share ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
ASN and FDA: Recognizing Ways to Increase Diversity in Clinical Trials
ASN Executive Vice President, Tod Ibrahim and ASN Past President, Jonathan Himmelfarb, MD, FASN, speak with Jonca Bull, MD and Patrick Archdeacon, MD from the FDA about ways to improve disparities in clinical trials.
View all episodes
By American Society of NephrologyASN Executive Vice President, Tod Ibrahim and ASN Past President, Jonathan Himmelfarb, MD, FASN, speak with Jonca Bull, MD and Patrick Archdeacon, MD from the FDA about ways to improve disparities in clinical trials.